4‑Methoxydalbergione inhibits esophageal carcinoma cell proliferation and migration by inactivating NF‑κB-Reference-Cited by-同舟云学术

4‑Methoxydalbergione inhibits esophageal carcinoma cell proliferation and migration by inactivating NF‑κB

Published:2023-01-12 Issue:2 Volume:49 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Li Ming¹,Xiao Yubo¹,Liu Pinyue¹,Wei Le¹,Zhang Ti¹,Xiang Ziye¹,Liu Xiaoyan¹,Zhang Keyun²,Zhong Qiaoqing³,Chen Fangzhi⁴

Affiliation:

1. Hunan Provincial Key Laboratory for Synthetic Biology of Traditional Chinese Medicine, Hunan University of Medicine, Huaihua, Hunan 418000, P.R. China

2. Department of Orthopedics, The First Affiliated Hospital of Hunan University of Medicine, Huaihua, Hunan 418000, P.R. China

3. Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA 02115, USA

4. Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference56 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Esophageal cancer: Emerging therapeutics;Rogers;Expert Opin Ther Targets,2022

3. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017;Fan;Cancer Med,2020

4. Epidemiology of esophageal cancer: Update in global trends, etiology and risk factors;Uhlenhopp;Clin J Gastroenterol,2020

5. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms;Huang;Pharmacol Ther,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identify GADD45G as a potential target of 4-methoxydalbergione in treatment of liver cancer: bioinformatics analysis and in vivo experiment;World Journal of Surgical Oncology;2023-10-13